Research and Development

The European Medicines Agency (EMA) has recently made changes to its process for the registration of micro, small or medium-sized …

AstraZeneca has appointed Rich Fante as regional vice president of the Americas, and Marion McCourt as chief operating officer of …

Thomas Thorp has been promoted to senior director of corporate affairs at Lilly UK. Thorp will now lead all of …

A rival to Roche and Novartis’ drug Lucentis has received FDA approval for a common form of eye disease. Eylea …

Gilead Sciences is to buy Pharmasset for $11 billion in a bid to become a leader in hepatitis C treatment.The …

Celgene has opened new UK headquarters in London as its haematology-based business expands. The firm says it has decided to …

Earlier this year we reported on progress in the consolidation of the UK medicines legislation and that the Medicines and …

The European Medicines Agency has accepted Pfizer’s arthritis drug tofacitinib for review.Tofacitinib is a novel, oral JAK inhibitor being studied …

The European Medicines Agency’s new executive director Guido Rasi has appointed Andreas Pott as deputy executive director. Pott’s appointment follows …

The FDA has pulled Avastin’s breast cancer licence in the US after the drug failed to prove its safety and …

Dipankar Bhattacharjee has been promoted to vice president of UK and Teva Northern Europe. Teva said that as part of …

AstraZeneca has thrown more light on the pending closure of its UK R&D site in Charnwood, saying that 90% of …

One of the world’s first stem cell trials has been put on hold due to ‘uncertain economic conditions’.Geron, the firm undertaking …

The European Commission and the European pharma industry have unveiled plans to accelerate the discovery and development of new antibiotics. …